*Kota Iida1,2, Makito Miyake2, Nobutaka Nishimura2, Hiroaki Matsumoto3, Hideyasu Matsuyama3, Yuya Fujiwara4, Kazumasa Komura4, Teruo Inamoto4, Haruhito Azuma4, Hiroaki Shiina5, Masaya Yonemori6, Hideki Enokida6, Masayuki Nakagawa6, Hideo Fukuhara7, Keiji Inoue7, Takashi Yoshida8, Hidefumi Kinoshita8, Tadashi Matsuda8, Tomomi Fujii9, Kiyohide Fujimoto2 (1. Department of Urology, Tane general hospital, Osaka, Japan, 2. Department of Urology, Nara Medical University, Nara, Japan, 3. Department of Urology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan, 4. Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan, 5. Department of Urology, Shimane University School of Medicine, Shimane, Japan, 6. f Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 7. Department of Urology, Kochi Medical School, Kochi, Japan, 8. Department of Urology and Andrology, Kansai Medical University, Osaka, Japan, 9. Department of Diagnostic Pathology, Nara Medical University, Nara, Japan)
Session information
Oral case study/Oral presentation
Oral Presentation 4
Sat. Oct 28, 2023 10:30 AM - 11:20 AM Room 2: Subaru EAST (Hotel Nikko Tsukuba Annex Bldg.1F)
Chair: Toshiyuki Kamoto (University of Miyazaki), Cheryn Song (University of Ulsan College of Medicine, Asan Medical Center)
[Toshiyuki Kamoto's Biography]
Toshiyuki Kamoto, M.D., Ph.D. Date of Birth: 1st. Oct. 1961 Dr. Toshiyuki Kamoto graduated from Kyoto University in 1987. From 1995 to 1997, he was an Assistant Professor of the Department of Pathology and Biology of Diseases, Graduate School of Medicine Kyoto University. From 1997 to 2009 he was an Assistant and an Associate Professor of the Department of Urology, Kyoto University. Since 2009, he has been a Professor and Chairman of the Department of Urology, University of Miyazaki. He serves as a Vice Director of University of Miyazaki Hospital since 2011.
He is an active member of the Japanese Urological Association (JUA), Japanese Society of Clinical Oncology (JSCO), Japanese Society of Medical Oncology (JSMO), Japanese society of Endourology and Robotics (JSER), AUA, EAU, and SIU. His specialty is urology, especially urological malignancy, endoscopic and laparoscopic surgery.
[Cheryn Song's Biography]
I graduated from Yonsei University in 1999, and after obtaining my medical license, I began my training at Asan Medical Center. Completing my urology residency in 2004, I continued for fellowship training at the same hospital until 2007 in the field of urologic oncology while at the same time obtaining a PhD degree at the University of Ulsan with a thesis on how TGF-b downregulated IL-2-induced activation of signal transduction in human renal cell carcinoma. Since being appointed as clinical instructor in 2007, I have been working at Asan Medical Center specializing in laparoscopic and robotic surgeries for urologic cancers. Besides the urologic training and education, I completed studies at the Johns Hopkins University Bloomberg School of Public Health in 2012 with a degree in master’s in public health.
Outside my institution, I had several fellowship opportunities. In 2006, I was a visiting fellow at Nagoya University (Professor Ono and Professor Hattori) where I was trained in the principles of urologic laparoscopy. In 2012, I was a clinical research fellow in the kidney cancer research team at the Sidney Kimmel Prostate and Urologic Cancer Center in Memorial Sloan-Kettering Cancer Center, NY, USA (Dr. Coleman and Dr. Russo). Through these fellowships, I was able to focus my clinical and research scopes more into renal cancer. My current focus on research includes epidemiologic and treatment outcomes studies in localized as well as metastatic renal cell carcinoma, and renal functional changes following nephron-sparing surgeries. I am also deeply involved in identification and management of hereditary renal cancer syndromes, running a special clinic of multidisciplinary team with medical geneticist, neurosurgeon, pancreatic surgeon, ophthalmologist, endocrine surgeon, and a radiologist specialist. In the laboratory, I have been working on molecular signaling and markers of progression in kidney cancer. Partnering with computer specialists, I have been involved in developing navigation software for robotic surgery and artificial intelligence models to predict oncological as well as functional outcomes following nephron-sparing surgery.
Professional society I am most actively engaged in is the Korean Urological Oncology Society, where I have served on the educational committee, Blue Ribbon Campaign committee, and the international relations committee. I have co-founded the kidney cancer research committee which became the Korean Renal Cancer Study Group, actively collaborating multi-institutional research and hosting biannual kidney cancer-focused conferences. Currently, I am the vice president of international relations and the organizing committee for the East Asia Urological Oncology Society.
*Kaoru Murakami1, Hajime Takamori1, Takuro Sunada1, Jin Kono1, Takayuki Sumiyoshi1, Yuki Kita1, Kimihiko Masui1, Takayuki Goto1, Ryoichi Saito1, Takashi Kobayashi1 (1. Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan)
*Keishiro Fukumoto1, Yota Yasumizu1, Nobuyuki Tanaka1, Toshikazu Takeda1, Kazuhiro Matsumoto1, Shinya Morita1, Takeo Kosaka1, Ryuichi Mizuno1, Hiroshi Asanuma1, Mototsugu Oya1 (1. Department of Urology, Keio University School of Medicine)
*Noriya Yamaguchi1, Shuichi Morizane1, Hiroshi Yamane1, Ryutaro Shimizu1, Ryoma Nishikawa1, Yusuke Kimura1, Katsuya Hikita1, Masashi Honda1, Atsushi Takenaka1 (1. Department of Surgery, Division of Urology, Faculty of Medicine Tottori University)
*Kotoe Matsuda1, Takashi Kawahara1, Masanobu Shiga1, Yoshiyuki Nagumo1, Atsushi Ikeda1, Tomokazu Kimura1, Akio Hoshi1, Hiromitsu Negoro1, Hiroyuki Nishiyam1 (1. Department of Urology, University of Tsukuba Hospital, Ibaraki, Japan)